Publication | Closed Access

Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis

HemodialysisUrologyRenal FunctionMedicineKidney FailurePharmacologyDialysis TherapyPharmacotherapyChronic Kidney DiseasePlasma MethylargininesNephrologyOxidative Stress